Oncology and Hematology - Global Oncology Academy

1-16 of 722

Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
1.50 credits
In-Person Event
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
September 12, 2026
Seoul
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Susana Campos, MD, MPH; Robert Coleman, MD, FACOG
1.00 credit
- Susana Campos, MD, MPH
- Robert Coleman, MD, FACOG
- Debra Richardson, MD
1.00 credit
CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas
1.00 credit
Interpreting and Applying cGVHD Clinical Trial Data
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®
Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP; Christopher Graham, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Christopher Graham, MD
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Project Oncology®
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS; Neil M. Iyengar, MD
- Alexandria May, PharmD, BCPS
- Neil M. Iyengar, MD
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
CME/CE
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
Alexandria May, PharmD, BCPS; Tiffany Traina, MD, FASCO
- Alexandria May, PharmD, BCPS
- Tiffany Traina, MD, FASCO
MCED Testing for Breast Cancer: Opportunities and Limitations
MCED Testing for Breast Cancer: Opportunities and Limitations
On the Frontlines of Metastatic Breast Cancer
MCED Testing for Breast Cancer: Opportunities and Limitations
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
How Genetic Testing Guides Personalized mBC Care
How Genetic Testing Guides Personalized mBC Care
On the Frontlines of Metastatic Breast Cancer
How Genetic Testing Guides Personalized mBC Care
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Project Oncology®
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
- Jorge Nieva, MD
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
- Jorge Nieva, MD
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
- Urs Weber, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Project Oncology®
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
- Urs Weber, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
- Urs Weber, MD
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Project Oncology®
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Urs Weber, MD
- Urs Weber, MD

Prev
1
2
3
…
45
46
Next

1/6